Your browser doesn't support javascript.
loading
Nivolumab before and after allogeneic hematopoietic cell transplantation.
Covut, F; Pinto, R; Cooper, B W; Tomlinson, B; Metheny, L; Malek, E; Lazarus, H M; de Lima, M; Caimi, P F.
Afiliação
  • Covut F; Stem Cell Transplant Program, University Hospitals Seidman Cancer Center, Cleveland, OH, USA.
  • Pinto R; Stem Cell Transplant Program, University Hospitals Seidman Cancer Center, Cleveland, OH, USA.
  • Cooper BW; Stem Cell Transplant Program, University Hospitals Seidman Cancer Center, Cleveland, OH, USA.
  • Tomlinson B; Case Comprehensive Cancer Center, Cleveland, OH, USA.
  • Metheny L; Stem Cell Transplant Program, University Hospitals Seidman Cancer Center, Cleveland, OH, USA.
  • Malek E; Case Comprehensive Cancer Center, Cleveland, OH, USA.
  • Lazarus HM; Stem Cell Transplant Program, University Hospitals Seidman Cancer Center, Cleveland, OH, USA.
  • de Lima M; Case Comprehensive Cancer Center, Cleveland, OH, USA.
  • Caimi PF; Stem Cell Transplant Program, University Hospitals Seidman Cancer Center, Cleveland, OH, USA.
Bone Marrow Transplant ; 52(7): 1054-1056, 2017 07.
Article em En | MEDLINE | ID: mdl-28346414
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Transplante de Células-Tronco Hematopoéticas / Anticorpos Monoclonais Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Transplante de Células-Tronco Hematopoéticas / Anticorpos Monoclonais Idioma: En Ano de publicação: 2017 Tipo de documento: Article